Home > > > Report Detail

Global Anti-Obesity Prescription Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 129

Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.

Scope of the Report:

This report focuses on the Anti-Obesity Prescription Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Anti-Obesity Prescription Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- F Hoffmann La Roche Ltd

- Orexigen Therapeutics, Inc

- Novo Nordisk A/s

- Arena Pharmaceuticals, Inc

- Glaxosmithkline

- Vivus, Inc

- Boehringer Ingelheim

- Alizyme

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Orlistat

- Phentermine and Topiramate

- Bupropion and Naltrexone

- Lorcaserin

- Liraglutide

Market Segment by Applications, can be divided into

- Pediatric

- Adult

There are 15 Chapters to deeply display the global Anti-Obesity Prescription Drugs market.

Chapter 1, to describe Anti-Obesity Prescription Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Obesity Prescription Drugs, with sales, revenue, and price of Anti-Obesity Prescription Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Prescription Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Obesity Prescription Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Obesity Prescription Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Anti-Obesity Prescription Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Anti-Obesity Prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Orlistat
1.2.2 Phentermine and Topiramate
1.2.3 Bupropion and Naltrexone
1.2.4 Lorcaserin
1.2.5 Liraglutide
1.3 Market Analysis by Applications
1.3.1 Pediatric
1.3.2 Adult
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F Hoffmann La Roche Ltd
2.1.1 Business Overview
2.1.2 Anti-Obesity Prescription Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Orexigen Therapeutics, Inc
2.2.1 Business Overview
2.2.2 Anti-Obesity Prescription Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk A/s
2.3.1 Business Overview
2.3.2 Anti-Obesity Prescription Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Arena Pharmaceuticals, Inc
2.4.1 Business Overview
2.4.2 Anti-Obesity Prescription Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Glaxosmithkline
2.5.1 Business Overview
2.5.2 Anti-Obesity Prescription Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Vivus, Inc
2.6.1 Business Overview
2.6.2 Anti-Obesity Prescription Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Vivus, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Anti-Obesity Prescription Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Alizyme
2.8.1 Business Overview
2.8.2 Anti-Obesity Prescription Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Obesity Prescription Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Obesity Prescription Drugs Market Analysis by Regions
4.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
4.5 South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5 North America Anti-Obesity Prescription Drugs by Countries
5.1 North America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Obesity Prescription Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Obesity Prescription Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6 Europe Anti-Obesity Prescription Drugs by Countries
6.1 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Obesity Prescription Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Obesity Prescription Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.3 UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.4 France Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Obesity Prescription Drugs by Countries
7.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.5 India Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8 South America Anti-Obesity Prescription Drugs by Countries
8.1 South America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Obesity Prescription Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Obesity Prescription Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Obesity Prescription Drugs by Countries
9.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
10 Global Anti-Obesity Prescription Drugs Market Segment by Type
10.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2013-2018)
10.2 Orlistat Sales Growth and Price
10.2.1 Global Orlistat Sales Growth (2013-2018)
10.2.2 Global Orlistat Price (2013-2018)
10.3 Phentermine and Topiramate Sales Growth and Price
10.3.1 Global Phentermine and Topiramate Sales Growth (2013-2018)
10.3.2 Global Phentermine and Topiramate Price (2013-2018)
10.4 Bupropion and Naltrexone Sales Growth and Price
10.4.1 Global Bupropion and Naltrexone Sales Growth (2013-2018)
10.4.2 Global Bupropion and Naltrexone Price (2013-2018)
10.5 Lorcaserin Sales Growth and Price
10.5.1 Global Lorcaserin Sales Growth (2013-2018)
10.5.2 Global Lorcaserin Price (2013-2018)
10.6 Liraglutide Sales Growth and Price
10.6.1 Global Liraglutide Sales Growth (2013-2018)
10.6.2 Global Liraglutide Price (2013-2018)
11 Global Anti-Obesity Prescription Drugs Market Segment by Application
11.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2013-2018)
11.2 Pediatric Sales Growth (2013-2018)
11.3 Adult Sales Growth (2013-2018)
12 Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Obesity Prescription Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.3 Anti-Obesity Prescription Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Obesity Prescription Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Anti-Obesity Prescription Drugs Picture
Table Product Specifications of Anti-Obesity Prescription Drugs
Figure Global Sales Market Share of Anti-Obesity Prescription Drugs by Types in 2017
Table Anti-Obesity Prescription Drugs Types for Major Manufacturers
Figure Orlistat Picture
Figure Phentermine and Topiramate Picture
Figure Bupropion and Naltrexone Picture
Figure Lorcaserin Picture
Figure Liraglutide Picture
Figure Anti-Obesity Prescription Drugs Sales Market Share by Applications in 2017
Figure Pediatric Picture
Figure Adult Picture
Figure United States Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Table F Hoffmann La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Type and Applications
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Orexigen Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Type and Applications
Table Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk A/s Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Type and Applications
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Arena Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Type and Applications
Table Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Anti-Obesity Prescription Drugs Type and Applications
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vivus, Inc Basic Information, Manufacturing Base and Competitors
Table Vivus, Inc Anti-Obesity Prescription Drugs Type and Applications
Table Vivus, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Type and Applications
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alizyme Basic Information, Manufacturing Base and Competitors
Table Alizyme Anti-Obesity Prescription Drugs Type and Applications
Table Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2016-2017)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2017
Table Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2016-2017)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales by Regions (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Regions (2013-2018)
Table Global Anti-Obesity Prescription Drugs Revenue by Regions (2013-2018)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2013
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2017
Figure North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table North America Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2013
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2017
Table North America Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Table North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2013
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2017
Figure United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table Europe Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Table Europe Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2016
Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2017
Figure Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure France Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries 2017
Figure China Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure India Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table South America Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table South America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2017
Table South America Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Table South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2017
Figure Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure UAE Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales by Type (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales Share by Type (2013-2018)
Table Global Anti-Obesity Prescription Drugs Revenue by Type (2013-2018)
Table Global Anti-Obesity Prescription Drugs Revenue Share by Type (2013-2018)
Figure Global Orlistat Sales Growth (2013-2018)
Figure Global Orlistat Price (2013-2018)
Figure Global Phentermine and Topiramate Sales Growth (2013-2018)
Figure Global Phentermine and Topiramate Price (2013-2018)
Figure Global Bupropion and Naltrexone Sales Growth (2013-2018)
Figure Global Bupropion and Naltrexone Price (2013-2018)
Figure Global Lorcaserin Sales Growth (2013-2018)
Figure Global Lorcaserin Price (2013-2018)
Figure Global Liraglutide Sales Growth (2013-2018)
Figure Global Liraglutide Price (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales by Application (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales Share by Application (2013-2018)
Figure Global Adult Sales Growth (2013-2018)
Figure Global Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Regions (2018-2023)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
Figure Europe Sales Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
Figure South America Sales Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2018-2023)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2018-2023)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2018-2023)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs